Related Experiment Video
Updated: Aug 6, 2026
CO2-Lasertonsillotomy Under Local Anesthesia in Adults
Published on: November 6, 2019
Comparative outcomes of intracapsular and total tonsillectomy for obstructive sleep apnea in children with Trisomy 21
Beverly J Fu1, Helen Xu1, Alyssa J Smith1
1Department of Otolaryngology-Head and Neck Surgery, Stanford Healthcare, USA.
Insights
Intracapsular tonsillectomy (IT) offers similar obstructive sleep apnea (OSA) control to total tonsillectomy (TT) in children with Trisomy 21 (T21). IT significantly reduces postoperative complications, making it a safer first-line surgical option for this population.
Area of Science:
- Pediatric Otolaryngology
- Sleep Medicine
- Genetics and Rare Diseases
Background:
- Children with Trisomy 21 (T21) face elevated risks for obstructive sleep apnea (OSA) and surgical complications.
- Intracapsular tonsillectomy (IT) is linked to reduced postoperative issues, but its long-term effectiveness versus total tonsillectomy (TT) is debated.
Purpose of the Study:
- To evaluate and compare the safety and efficacy of IT versus TT for managing OSA in pediatric patients with T21.
Main Methods:
- A retrospective cohort study analyzed 176 children (aged 2-18 years) with T21 who underwent IT or TT between 2005-2025.
- Exclusion criteria included concurrent airway surgeries.
- Key outcomes measured were postoperative complications, polysomnography (PSG) changes, symptom recurrence, and OSA-free survival.
Main Results:
- No significant differences were found in preoperative OSA severity or tonsil size between the IT and TT groups.
- Postoperative complications, including poor oral intake and bleeding, were significantly lower following IT compared to TT.
- Both IT and TT demonstrated comparable improvements in apnea-hypopnea index (AHI) and OSA resolution rates.
Conclusions:
- Intracapsular tonsillectomy achieves comparable obstructive sleep apnea control to total tonsillectomy in children with Trisomy 21.
- IT is associated with substantially lower perioperative morbidity, supporting its role as a safe and effective primary surgical strategy.
Introduction:
Children with Trisomy 21 (T21) are at high risk for obstructive sleep apnea (OSA) and perioperative complications. Intracapsular tonsillectomy (IT) is associated with reduced postoperative morbidity, but its long-term efficacy compared to total tonsillectomy (TT) remains debated.
Objectives:
To compare the safety and efficacy of IT versus TT for OSA in children with T21.
Methods:
A retrospective cohort study was conducted of patients aged 2-18 years with T21 who underwent tonsillectomies with/without adenoidectomy between 2005 and 2025 at a tertiary center. Patients undergoing concurrent airway procedures were excluded. Outcomes included postoperative complications, polysomnography (PSG) changes, symptom recurrence, and OSA-symptom-free survival.
Results:
Among 176 patients (mean age 5.9 years; 54.0% female), 109 underwent TT and 67 IT. Preoperative OSA severity and tonsil size did not differ. Postoperative return visits were significantly higher after TT (17.4% vs 1.5%, p = 0.001) for poor oral intake (12.8% vs 1.5%, p = 0.010) and bleeding (6.4% vs 0.0%, p = 0.045). Improvements in AHI (53.4% TT vs 53.1% IT, p = 1.00) and OSA resolution (19.0% vs 21.9%, p = 0.787) were comparable. Unadjusted OSA recurrence was higher after TT, but this difference was not significant after adjusting for surgery year and follow-up duration (HR 1.10, 95% CI 0.54-2.25, p = 0.785). No patient undergoing IT required completion tonsillectomy despite tonsillar regrowth being observed in 5 patients (7.5%), all of whom were managed conservatively.
Conclusion:
Intracapsular tonsillectomy provides equivalent OSA control with lower perioperative morbidity compared with total tonsillectomy, supporting IT as a safe and effective first-line surgical approach for children with T21.
